MyFinsight
Home
Blog
About
Contact
Download
Download image
Net decrease in cash
and cash...
-$3,285K
Accounts payable
$4,611K
Accrued expenses and
other current...
$3,918K
Share-based compensation
$1,686K
Depreciation and
amortization
$1,616K
Amortization of debt issuance
costs and debt...
$1,211K
Accounts receivable
-$864K
Prepaid expenses and
other current assets
-$144K
Proceeds from employee
stock purchase plan
$220K
Common stock issued for
options exercised
$21K
Net cash and cash
equivalents used in...
-$2,215K
Net cash and cash
equivalents used in...
-$1,042K
Net cash and cash
equivalents used in...
-$28K
Canceled cashflow
$14,050K
Canceled cashflow
$241K
Inventories
$7,415K
Purchases of property and
equipment
$1,042K
Payments made for
financing of insurance...
$260K
Change in fair value of
liability classified...
$4,996K
Net loss
-$2,492K
Other receivables
$994K
Change in operating
leases
-$186K
Change in fair value of
liability classified...
-$168K
Other assets
$14K
Principal payments on
financing leases
$9K
Back
Back
Cash Flow
Oncology Institute, Inc. (DFPH)
Oncology Institute, Inc. (DFPH)
source: myfinsight.com